TY - JOUR
T1 - Frequency of Medical Reversal Among Published Randomized Controlled Trials Assessing Cardiopulmonary Resuscitation (CPR)
AU - Herrera-Perez, Diana
AU - Fox-Lee, Ryan
AU - Bien, Jeffrey
AU - Prasad, Vinay
N1 - Funding Information:
Potential Competing Interests: Dr Prasad receives royalties from his book Ending Medical Reversal; his work is funded by the Laura and John Arnold Foundation ; he has received honoraria for Grand Rounds/lectures from several universities, medical centers, nonprofit groups, and professional societies; and he is a writer for Medscape and the host of the Plenary Session podcast, which receives crowdfunding support through the Patreon platform. Drs Herrera-Perez, Fox-Lee, and Bien report no competing interests.
Publisher Copyright:
© 2020 Mayo Foundation for Medical Education and Research
PY - 2020/5
Y1 - 2020/5
N2 - Objective: To characterize what proportion of all randomized controlled trials (RCTs) among patients experiencing cardiac arrest find that an established practice is ineffective or harmful, that is, a medical reversal. Methods: We reviewed a database of all published RCTs of cardiac arrest patient populations between 1995 and 2014. Articles were classified on the basis of whether they tested a new or existing therapy and whether results were positive or negative. A reversal was defined as a negative RCT of an established practice. Further review and categorization were performed to confirm that reversals were supported by subsequent systematic review, as well as to identify the type of medical practice studied in each reversal. This study was conducted from October 2017 to June 17, 2019. Results: We reviewed 92 original articles, 76 of which could be conclusively categorized. Of these, 18 (24%) articles examined a new medical practice, whereas 58 (76%) tested an established practice. A total of 18 (24%) studies had positive findings, whereas 58 (76%) reached a negative conclusion. Of the 58 articles testing existing standard of care, 44 (76%) reversed that practice, whereas 14 (24%) reaffirmed it. Conclusion: Reversal of cardiopulmonary resuscitation practices is widespread. This investigation sheds new light on low-value practices and patterns of medical research and suggests that novel resuscitation practices have low pretest probability and should be empirically tested with rigorous trials before implementation.
AB - Objective: To characterize what proportion of all randomized controlled trials (RCTs) among patients experiencing cardiac arrest find that an established practice is ineffective or harmful, that is, a medical reversal. Methods: We reviewed a database of all published RCTs of cardiac arrest patient populations between 1995 and 2014. Articles were classified on the basis of whether they tested a new or existing therapy and whether results were positive or negative. A reversal was defined as a negative RCT of an established practice. Further review and categorization were performed to confirm that reversals were supported by subsequent systematic review, as well as to identify the type of medical practice studied in each reversal. This study was conducted from October 2017 to June 17, 2019. Results: We reviewed 92 original articles, 76 of which could be conclusively categorized. Of these, 18 (24%) articles examined a new medical practice, whereas 58 (76%) tested an established practice. A total of 18 (24%) studies had positive findings, whereas 58 (76%) reached a negative conclusion. Of the 58 articles testing existing standard of care, 44 (76%) reversed that practice, whereas 14 (24%) reaffirmed it. Conclusion: Reversal of cardiopulmonary resuscitation practices is widespread. This investigation sheds new light on low-value practices and patterns of medical research and suggests that novel resuscitation practices have low pretest probability and should be empirically tested with rigorous trials before implementation.
UR - http://www.scopus.com/inward/record.url?scp=85084059469&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084059469&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2020.01.036
DO - 10.1016/j.mayocp.2020.01.036
M3 - Article
C2 - 32370852
AN - SCOPUS:85084059469
SN - 0025-6196
VL - 95
SP - 889
EP - 910
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 5
ER -